214 related articles for article (PubMed ID: 36239901)
1. The role of epigenetics in T-cell lymphoma.
Yamagishi M
Int J Hematol; 2022 Dec; 116(6):828-836. PubMed ID: 36239901
[TBL] [Abstract][Full Text] [Related]
2. [The role of epigenetics in malignant lymphoma].
Yamagishi M
Rinsho Ketsueki; 2022; 63(9):1157-1166. PubMed ID: 36198541
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma.
Zhang P; Zhang M
Clin Epigenetics; 2020 Nov; 12(1):169. PubMed ID: 33160401
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic dysregulation in follicular lymphoma.
Araf S; Okosun J; Koniali L; Fitzgibbon J; Heward J
Epigenomics; 2016 Jan; 8(1):77-84. PubMed ID: 26698557
[TBL] [Abstract][Full Text] [Related]
5. Methylation alterations and advance of treatment in lymphoma.
Liu MK; Sun XJ; Gao XD; Qian Y; Wang L; Zhao WL
Front Biosci (Landmark Ed); 2021 Sep; 26(9):602-613. PubMed ID: 34590470
[TBL] [Abstract][Full Text] [Related]
6. Precision Targeting with EZH2 and HDAC Inhibitors in Epigenetically Dysregulated Lymphomas.
Lue JK; Prabhu SA; Liu Y; Gonzalez Y; Verma A; Mundi PS; Abshiru N; Camarillo JM; Mehta S; Chen EI; Qiao C; Nandakumar R; Cremers S; Kelleher NL; Elemento O; Amengual JE
Clin Cancer Res; 2019 Sep; 25(17):5271-5283. PubMed ID: 30979734
[TBL] [Abstract][Full Text] [Related]
7. Aging and Age-Related Epigenetic Drift in the Pathogenesis of Leukemia and Lymphomas: New Therapeutic Targets.
Allegra A; Caserta S; Mirabile G; Gangemi S
Cells; 2023 Sep; 12(19):. PubMed ID: 37830606
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of lymphomas in the era of epigenetics.
Chebly A; Chouery E; Ropio J; Kourie HR; Beylot-Barry M; Merlio JP; Tomb R; Chevret E
Blood Rev; 2021 Jul; 48():100782. PubMed ID: 33229141
[TBL] [Abstract][Full Text] [Related]
9. Bcl-2-negative IGH-BCL2 translocation-negative follicular lymphoma of the thyroid differs genetically and epigenetically from Bcl-2-positive IGH-BCL2 translocation-positive follicular lymphoma.
Hamamoto Y; Kukita Y; Kitamura M; Kurashige M; Masaie H; Fuji S; Ishikawa J; Honma K; Wakasa T; Hanamoto H; Hirokawa M; Suzuki A; Morii E; Nakatsuka SI
Histopathology; 2021 Oct; 79(4):521-532. PubMed ID: 33829512
[TBL] [Abstract][Full Text] [Related]
10. Somatic alterations and dysregulation of epigenetic modifiers in cancers.
Aumann S; Abdel-Wahab O
Biochem Biophys Res Commun; 2014 Dec; 455(1-2):24-34. PubMed ID: 25111821
[TBL] [Abstract][Full Text] [Related]
11. [Epigenetic abnormalities in non-Hodgkin lymphomas].
Furukawa Y
Rinsho Ketsueki; 2021; 62(9):1367-1381. PubMed ID: 34615796
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic alterations in hematopoietic malignancies.
Chung YR; Schatoff E; Abdel-Wahab O
Int J Hematol; 2012 Oct; 96(4):413-27. PubMed ID: 23015417
[TBL] [Abstract][Full Text] [Related]
13. Targeting epigenetic regulators in the treatment of T-cell lymphoma.
Ahmed N; Feldman AL
Expert Rev Hematol; 2020 Feb; 13(2):127-139. PubMed ID: 31903826
[No Abstract] [Full Text] [Related]
14. Targeting Excessive EZH1 and EZH2 Activities for Abnormal Histone Methylation and Transcription Network in Malignant Lymphomas.
Yamagishi M; Hori M; Fujikawa D; Ohsugi T; Honma D; Adachi N; Katano H; Hishima T; Kobayashi S; Nakano K; Nakashima M; Iwanaga M; Utsunomiya A; Tanaka Y; Okada S; Tsukasaki K; Tobinai K; Araki K; Watanabe T; Uchimaru K
Cell Rep; 2019 Nov; 29(8):2321-2337.e7. PubMed ID: 31747604
[TBL] [Abstract][Full Text] [Related]
15. Drugging the epigenome in the age of precision medicine.
Feehley T; O'Donnell CW; Mendlein J; Karande M; McCauley T
Clin Epigenetics; 2023 Jan; 15(1):6. PubMed ID: 36631803
[TBL] [Abstract][Full Text] [Related]
16. Clinical epigenomics for cardiovascular disease: Diagnostics and therapies.
Fischer MA; Vondriska TM
J Mol Cell Cardiol; 2021 May; 154():97-105. PubMed ID: 33561434
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic alterations and advancement of lymphoma treatment.
Zhuang S; Yang Z; Cui Z; Zhang Y; Che F
Ann Hematol; 2024 May; 103(5):1435-1454. PubMed ID: 37581713
[TBL] [Abstract][Full Text] [Related]
18. Understanding epigenomics based on the rice model.
Lu Y; Zhou DX; Zhao Y
Theor Appl Genet; 2020 May; 133(5):1345-1363. PubMed ID: 31897514
[TBL] [Abstract][Full Text] [Related]
19. The many layers of epigenetic dysfunction in B-cell lymphomas.
Jiang Y; Dominguez PM; Melnick AM
Curr Opin Hematol; 2016 Jul; 23(4):377-84. PubMed ID: 27055146
[TBL] [Abstract][Full Text] [Related]
20. Investigation of epigenetics in kidney cell biology.
Li LX; Agborbesong E; Zhang L; Li X
Methods Cell Biol; 2019; 153():255-278. PubMed ID: 31395383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
